What are the challenges in targeting RTKs in Cancer?
Despite the success of RTK-targeted therapies, there are several challenges, including the development of drug resistance, off-target effects, and tumor heterogeneity. Tumor cells can develop mutations that confer resistance to RTK inhibitors or activate alternative signaling pathways to sustain growth and survival.
